New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Jaydev Thakkar, MBA
Advertisement
Jaydev Thakkar, MBA, MCA, is Chief Operating Officer of Biofourmis
Articles by Jaydev Thakkar, MBA
Advertisement
Latest Updated Articles
How Today’s Digitally Driven Research Could Drive CAR T-cell Therapy Protocols of the FuturePublished: September 25th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating AI Across Legacy Clinical Trial Systems
2
Reimagining Clinical Operations Through Artificial Intelligence
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
